Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 100.00
0.00 (0.00%)
Feb 11, 2026, 11:53 AM CST
Acer Medical Revenue
Acer Medical had revenue of 30.12M TWD in the half year ending June 30, 2025, with 311.77% growth. This brings the company's revenue in the last twelve months to 55.10M, up 21.60% year-over-year. In the year 2024, Acer Medical had annual revenue of 50.16M with 82.73% growth.
Revenue (ttm)
55.10M
Revenue Growth
+21.60%
P/S Ratio
27.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.16M | 22.71M | 82.73% |
| Dec 31, 2023 | 27.45M | 14.39M | 110.17% |
| Dec 31, 2022 | 13.06M | 3.43M | 35.66% |
| Dec 31, 2021 | 9.63M | 8.61M | 849.41% |
| Dec 31, 2020 | 1.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Rossmax International | 3.82B |
| Perfect Medical Industry | 737.27M |
| Winston Medical Supply | 724.35M |
| GenMont Biotech Incorporation | 391.48M |
| Abnova (Taiwan) | 355.40M |
| NeoCore Technology | 190.10M |